Abstract
The recent definition that chronic obstructive pulmonary disease (COPD) is a “preventable and treatable disease state characterized by airflow limitation that is not fully reversible” reminds that the respiratory functional evaluation is an integral part in the diagnostic and follow-up process in this disease. This review has the scope to focus on some of the most debated pathophysiological and functional issues. One of these is how airflow obstruction occurs and progresses. To this aim, we will discuss the functional role of mucus, increased thickness of the submucosa and adventitia, airway smooth muscle, site of airway narrowing, collapsibility of the central airways, and loss of lung elastic recoil in decreasing flow. Then, we will present a functional clinical approach to the disease that covers the most important features of the disease, such as diagnosis, follow-up, severity assessment, lung hyperinflation, and bronchodilator response.
Keywords: Airflow limitation, airway narrowing, lung elastic recoil, lung hyperinflation, bronchodilation, pathology, lung function tests
Current Respiratory Medicine Reviews
Title: Structure and Function in COPD
Volume: 4 Issue: 4
Author(s): Riccardo Pellegrino, Giuseppe Coletta, Valter Gallo and Vito Brusasco
Affiliation:
Keywords: Airflow limitation, airway narrowing, lung elastic recoil, lung hyperinflation, bronchodilation, pathology, lung function tests
Abstract: The recent definition that chronic obstructive pulmonary disease (COPD) is a “preventable and treatable disease state characterized by airflow limitation that is not fully reversible” reminds that the respiratory functional evaluation is an integral part in the diagnostic and follow-up process in this disease. This review has the scope to focus on some of the most debated pathophysiological and functional issues. One of these is how airflow obstruction occurs and progresses. To this aim, we will discuss the functional role of mucus, increased thickness of the submucosa and adventitia, airway smooth muscle, site of airway narrowing, collapsibility of the central airways, and loss of lung elastic recoil in decreasing flow. Then, we will present a functional clinical approach to the disease that covers the most important features of the disease, such as diagnosis, follow-up, severity assessment, lung hyperinflation, and bronchodilator response.
Export Options
About this article
Cite this article as:
Pellegrino Riccardo, Coletta Giuseppe, Gallo Valter and Brusasco Vito, Structure and Function in COPD, Current Respiratory Medicine Reviews 2008; 4 (4) . https://dx.doi.org/10.2174/157339808786263770
DOI https://dx.doi.org/10.2174/157339808786263770 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
In Silico Prediction of Drug Properties
Current Medicinal Chemistry Pituitary Dysfunction as a Cause of Cardiovascular Disease
Current Pharmaceutical Design Comparison of High-Density Short Oligonucleotide Microarray Platforms
Current Bioinformatics Epigenetic Control of MicroRNA Expression and Aging
Current Genomics Chest Wall Mechanics in COPD
Current Respiratory Medicine Reviews Recent Updates on Peroxisome Proliferator-Activated Receptor δ Agonists for the Treatment of Metabolic Syndrome
Medicinal Chemistry Analysis and Prediction of Myristoylation Sites Using the mRMR Method, the IFS Method and an Extreme Learning Machine Algorithm
Combinatorial Chemistry & High Throughput Screening Usefulness of Salivary Drug Monitoring for Detecting Efflux Transporter Overexpression
Current Pharmaceutical Design Lipid Lowering Drugs and Gallstones: A Therapeutic Option?
Current Pharmaceutical Design Cardioregulatory Functions of Neuropeptides and Peptide Hormones in Insects
Protein & Peptide Letters Pathophysiological and Clinical Aspects of Iron Chelation Therapy in MDS
Current Pharmaceutical Design Vasopressin and Related Peptides; Potential Value in Diagnosis, Prognosis and Treatment of Clinical Disorders
Current Drug Metabolism Use of Recombinant Factor VII in Cardiac Surgery
Recent Patents on Cardiovascular Drug Discovery Serum N-terminal Pro-brain Natriuretic Peptide Level is Associated with the Development of Chronic Kidney Diseases in Patients with Type 2 Diabetes
Endocrine, Metabolic & Immune Disorders - Drug Targets Impact of Pulmonary Vascular Resistances in Heart Transplantation for Congenital Heart Disease
Current Cardiology Reviews Hypertension and Atrial Fibrillation: Any Change with the New Anticoagulants
Current Pharmaceutical Design Transfection of TGF-β shRNA by Using Ultrasound-targeted Microbubble Destruction to Inhibit the Early Adhesion Repair of Rats Wounded Achilles Tendon In vitro and In vivo
Current Gene Therapy Hyperthermia: From Diagnostic and Treatments to New Discoveries
Recent Patents on Biotechnology Routine use of Corticosteroids to Prevent Inflammation Response in Cardiac Surgery
Recent Patents on Cardiovascular Drug Discovery Nitric Oxide: Friendly Rivalry in Tuberculosis
Current Signal Transduction Therapy